Detailed information for compound 1845029

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 289.33 | Formula: C15H19N3O3
  • H donors: 2 H acceptors: 3 LogP: -1.65 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: NCCCC[C@H](n1c(C)nc2c(c1=O)cccc2)C(=O)O
  • InChi: 1S/C15H19N3O3/c1-10-17-12-7-3-2-6-11(12)14(19)18(10)13(15(20)21)8-4-5-9-16/h2-3,6-7,13H,4-5,8-9,16H2,1H3,(H,20,21)/t13-/m0/s1
  • InChiKey: LPJPBXGSBARHBF-ZDUSSCGKSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis DNA helicase recq, putative 0.0021 0.2859 0.5
Toxoplasma gondii ATP-dependent DNA helicase, RecQ family protein 0.0011 0.0182 0.0381
Entamoeba histolytica recQ family helicase, putative 0.001 0.0076 0.0265
Schistosoma mansoni blooms syndrome DNA helicase 0.0011 0.0182 0.0107
Loa Loa (eye worm) ATP-dependent DNA helicase 0.0021 0.2859 0.2726
Plasmodium falciparum ADP-dependent DNA helicase RecQ 0.0021 0.2859 0.5
Trichomonas vaginalis DNA helicase recq, putative 0.0021 0.2859 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 1 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0049 1 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0049 1 1
Treponema pallidum ATP-dependent DNA helicase 0.0011 0.0182 0.5
Loa Loa (eye worm) RecQ helicase 0.0021 0.2859 0.2726
Trichomonas vaginalis DNA helicase recq1, putative 0.0021 0.2859 0.5
Toxoplasma gondii ATP-dependent DNA helicase, RecQ family protein 0.0021 0.2859 1
Plasmodium falciparum ATP-dependent DNA helicase Q1 0.0021 0.2859 0.5
Entamoeba histolytica recQ family helicase, putative 0.0021 0.2859 1
Giardia lamblia Sgs1 DNA helicase, putative 0.0021 0.2859 0.5
Schistosoma mansoni DNA helicase recq1 0.0021 0.2859 0.2804
Entamoeba histolytica recQ family DNA helicase 0.0011 0.0182 0.0636
Toxoplasma gondii ATP-dependent DNA helicase, RecQ family protein 0.0021 0.2859 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0049 1 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0049 1 1
Schistosoma mansoni DNA helicase recq5 0.0021 0.2859 0.2804
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 1 1
Loa Loa (eye worm) hypothetical protein 0.0021 0.2859 0.2726
Loa Loa (eye worm) hypothetical protein 0.0011 0.0182 0.000000002293
Leishmania major ATP-dependent DEAD/H DNA helicase recQ, putative 0.0021 0.2859 0.5
Trypanosoma cruzi ATP-dependent DEAD/H DNA helicase recQ, putative 0.0021 0.2859 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 1 1
Plasmodium vivax ADP-dependent DNA helicase RecQ, putative 0.0011 0.0182 1
Trypanosoma brucei ATP-dependent DEAD/H DNA helicase recQ, putative 0.0021 0.2859 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0049 1 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Antibacterial activity against Escherichia coli at 100 ug after 24 hr by cup-plate method ChEMBL. No reference
Activity (functional) = 9.78 % Antimalarial activity against Plasmodium yoelii N-67 infected Swiss mouse assessed as parasitemia at 200 mg/kg, ip qd administered 4 days measured 24 hr post last treatment (Rvb = 12.36 +/- 1.14 %) ChEMBL. No reference
Activity (functional) = 17.5 % Antimalarial activity against Plasmodium yoelii N-67 infected Swiss mouse assessed as parasitemia at 200 mg/kg, ip qd administered 4 days measured on day 7 (Rvb = 19.5 +/- 0.76 %) ChEMBL. No reference
MST (functional) = 6.8 day Antimalarial activity against Plasmodium yoelii N-67 infected Swiss mouse assessed as mean survival time at 200 mg/kg, ip qd administered 4 days measured 24 hr post last treatment (Rvb = 8.2 +/- 0.86 days) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.